BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

401 related articles for article (PubMed ID: 24047526)

  • 1. The potential for genetically altered microglia to influence glioma treatment.
    Li W; Holsinger RM; Kruse CA; Flügel A; Graeber MB
    CNS Neurol Disord Drug Targets; 2013 Sep; 12(6):750-62. PubMed ID: 24047526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular profile of microglia under the influence of glioma.
    Li W; Graeber MB
    Neuro Oncol; 2012 Aug; 14(8):958-78. PubMed ID: 22573310
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microglia-glioma cross-talk: a two way approach to new strategies against glioma.
    Arcuri C; Fioretti B; Bianchi R; Mecca C; Tubaro C; Beccari T; Franciolini F; Giambanco I; Donato R
    Front Biosci (Landmark Ed); 2017 Jan; 22(2):268-309. PubMed ID: 27814616
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microglia in brain tumors.
    Graeber MB; Scheithauer BW; Kreutzberg GW
    Glia; 2002 Nov; 40(2):252-259. PubMed ID: 12379912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of microglia in glioma biology.
    Badie B; Schartner J
    Microsc Res Tech; 2001 Jul; 54(2):106-13. PubMed ID: 11455617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Glioma models.
    Dai C; Holland EC
    Biochim Biophys Acta; 2001 Aug; 1551(1):M19-27. PubMed ID: 11553418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FasL gene knock-down therapy enhances the antiglioma immune response.
    Jansen T; Tyler B; Mankowski JL; Recinos VR; Pradilla G; Legnani F; Laterra J; Olivi A
    Neuro Oncol; 2010 May; 12(5):482-9. PubMed ID: 20406899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene therapy for high-grade glioma.
    Iwami K; Natsume A; Wakabayashi T
    Neurol Med Chir (Tokyo); 2010; 50(9):727-36. PubMed ID: 20885107
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric low-grade gliomas and the need for new options for therapy: Why and how?
    Qaddoumi I; Sultan I; Broniscer A
    Cancer Biol Ther; 2009 Jan; 8(1):4-10. PubMed ID: 19164945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The neurobiology of gliomas: from cell biology to the development of therapeutic approaches.
    Westphal M; Lamszus K
    Nat Rev Neurosci; 2011 Aug; 12(9):495-508. PubMed ID: 21811295
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Alterations in the Brain Microenvironment in Diffusely Infiltrating Low-Grade Glioma.
    Torres D; Canoll P
    Neurosurg Clin N Am; 2019 Jan; 30(1):27-34. PubMed ID: 30470402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chimeric adeno-associated virus and bacteriophage: a potential targeted gene therapy vector for malignant glioma.
    Asavarut P; O'Neill K; Syed N; Hajitou A
    Ther Deliv; 2014; 5(9):975-90. PubMed ID: 25375341
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down-regulation of Aquaporin-1 mediates a microglial phenotype switch affecting glioma growth.
    Hu F; Huang Y; Semtner M; Zhao K; Tan Z; Dzaye O; Kettenmann H; Shu K; Lei T
    Exp Cell Res; 2020 Nov; 396(2):112323. PubMed ID: 33058832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical development of experimental virus-mediated gene therapy for malignant glioma.
    Rainov NG; Heidecke V
    Anticancer Agents Med Chem; 2011 Oct; 11(8):739-47. PubMed ID: 21707496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglia in the Brain Tumor Microenvironment.
    Cole AP; Hoffmeyer E; Chetty SL; Cruz-Cruz J; Hamrick F; Youssef O; Cheshier S; Mitra SS
    Adv Exp Med Biol; 2020; 1273():197-208. PubMed ID: 33119883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of Microglia for the Treatment of Glioma.
    Zhou S; Cisse B
    World Neurosurg; 2021 Oct; 154():222-227. PubMed ID: 34583499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion of the RNA regulator HuR in tumor-associated microglia and macrophages stimulates anti-tumor immunity and attenuates glioma growth.
    Wang J; Leavenworth JW; Hjelmeland AB; Smith R; Patel N; Borg B; Si Y; King PH
    Glia; 2019 Dec; 67(12):2424-2439. PubMed ID: 31400163
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of isocitrate dehydrogenase 1 mutation in 97 patients with glioma.
    Zhou YX; Wang JX; Feng M; Sun CM; Sun T; Chen GL; Du ZW
    J Mol Neurosci; 2012 Jul; 47(3):442-7. PubMed ID: 22113362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy of malignant glioma: recent advances in experimental and clinical studies.
    Sasaki M; Plate KH
    Ann Oncol; 1998 Nov; 9(11):1155-66. PubMed ID: 9862044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct roles of CSF family cytokines in macrophage infiltration and activation in glioma progression and injury response.
    Sielska M; Przanowski P; Wylot B; Gabrusiewicz K; Maleszewska M; Kijewska M; Zawadzka M; Kucharska J; Vinnakota K; Kettenmann H; Kotulska K; Grajkowska W; Kaminska B
    J Pathol; 2013 Jul; 230(3):310-21. PubMed ID: 23520016
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.